Trial Profile
Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tigecycline vs Clindamycin for the Treatment of Complicated Skin and Skin Structure Infections, Including Those Due to MRSA, in Pediatric Subject 8-17 Years
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 02 Aug 2022
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary) ; Clindamycin; Vancomycin
- Indications Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
- Focus Therapeutic Use
- Sponsors Wyeth Pharmaceuticals
- 30 Jul 2022 This trial has been completed in Belgium (End Date: 12 Dec 2014) according to European Clinical Trials Database record.
- 13 Jun 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 06 Jan 2017 This trial has been completed in Hungary, according to European Clinical Trials Database